VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-01573
Package ID: USCOURTS-cofc-1_17-vv-01573
Petitioner: Gary L. Larson
Filed: 2017-10-20
Decided: 2019-07-29
Vaccine: influenza
Vaccination date: 2014-10-23
Condition: Guillain-Barré Syndrome (“GBS”)
Outcome: compensated
Award amount USD: 60000

AI-assisted case summary:
Gary L. Larson filed a petition on October 20, 2017, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he developed Guillain-Barré Syndrome (GBS) as a result of an influenza vaccine he received on October 23, 2014. The respondent, the Secretary of Health and Human Services, filed a Rule 4(c) Report on September 17, 2018, conceding that Mr. Larson's GBS satisfied the criteria set forth in the Vaccine Injury Table and its Qualifications and Aids to Interpretation. Based on this concession, Special Master Katherine E. Oler issued a Ruling on Entitlement on September 18, 2018, finding Mr. Larson entitled to compensation for GBS and its related sequelae. Subsequently, the parties reached a proffer agreement for damages. On March 27, 2019, the respondent proffered a lump sum payment of $60,000.00. Special Master Oler adopted this proffer in a Decision Awarding Damages on July 29, 2019, awarding Mr. Larson a lump sum payment of $60,000.00, payable to him. The decision noted that Mr. Larson is a competent adult and no guardianship evidence was required. Petitioner was represented by Joseph Tedford McFadden, Jr. and Glen Howard Sturtevant, Jr. of Rawls Law Group. Respondent was represented by Jennifer Leigh Reynaud of the U.S. Department of Justice. The public decision was not designated for publication but was posted on the court's website.

Theory of causation field:
Petitioner Gary L. Larson alleged that he developed Guillain-Barré Syndrome (GBS) as a result of an influenza vaccine received on October 23, 2014. The respondent conceded that Petitioner satisfied the criteria set forth in the Vaccine Injury Table and its Qualifications and Aids to Interpretation for GBS. Based on this concession, Special Master Katherine E. Oler issued a Ruling on Entitlement on September 18, 2018, finding Petitioner entitled to compensation for GBS and its related sequelae. A subsequent proffer agreement led to a Decision Awarding Damages on July 29, 2019, where Special Master Oler awarded Petitioner a lump sum payment of $60,000.00. Petitioner was represented by Joseph Tedford McFadden, Jr. and Glen Howard Sturtevant, Jr. (Rawls Law Group), and Respondent was represented by Jennifer Leigh Reynaud (U.S. Department of Justice).

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_17-vv-01573-0
Date issued/filed: 2018-10-18
Pages: 2
Docket text: PUBLIC RULING (Originally filed: 09/18/2018) regarding 18 Ruling on Entitlement. Signed by Special Master Katherine E. Oler. (dd) Service on parties made.
--------------------------------------------------------------------------------
Case 1:17-vv-01573-UNJ Document 20 Filed 10/18/18 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 17-1573V
(Unpublished)
* * * * * * * * * * * * * * * * * * * * * * * * *
*
GARY L. LARSON, * Filed: September 18, 2018
*
Petitioner, * Special Master Oler
*
v. *
* Entitlement; Influenza (“Flu”) Vaccine;
SECRETARY OF HEALTH * Guillain-Barré Syndrome (“GBS”).
AND HUMAN SERVICES, *
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * *
Joseph Tedford McFadden, Jr., Rawls Law Group, Norfolk, VA, for Petitioner.
Jennifer Leigh Reynaud, U.S. Dep’t of Justice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT1
On October 20, 2017, Petitioner Gary L. Larson filed a petition seeking compensation
under the National Vaccine Injury Compensation Program.2 Petitioner alleges that he developed
Guillain-Barré Syndrome (“GBS”) as a result of an influenza (“flu”) vaccine that he received on
October 23, 2014.
In his Rule 4(c) Report, filed on September 17, 2018, Respondent recommends that
compensation be awarded in this case. Rule 4(c) Report at 1, ECF No. 17. Respondent states
that the medical evidence demonstrates Petitioner has “satisfied the criteria set forth in the
1 Although this ruling is not formally designated for publication, it will be posted nonetheless on the United States
Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the ruling’s inclusion of certain
kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within
which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or
financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the
disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise,
the whole decision will be available to the public. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,
100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”).
Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix).

Case 1:17-vv-01573-UNJ Document 20 Filed 10/18/18 Page 2 of 2
Vaccine Injury Table (“Table”) and the Qualifications and Aids to Interpretation (“QAI”) for
GBS.” Id. at 8. Accordingly, Respondent concludes that Petitioner is entitled to an award of
damages limited to Petitioner’s “GBS and its related sequelae only.” Id.
In light of Respondent’s concession, and based on my own review of the record (see
Section 13(a)(1); 42 C.F.R. § 100.3(a)(II)), I find that Petitioner is entitled to compensation for
an injury that was caused-in-fact by a vaccination.
IT IS SO ORDERED.
s/ Katherine E. Oler
Katherine E. Oler
Special Master
2

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_17-vv-01573-1
Date issued/filed: 2019-07-29
Pages: 4
Docket text: PUBLIC DECISION (Originally filed: 3/28/2019) regarding 28 DECISION Stipulation/Proffer. Signed by Special Master Katherine E. Oler. (dd) Service on parties made.
--------------------------------------------------------------------------------
Case 1:17-vv-01573-UNJ Document 34 Filed 07/29/19 Page 1 of 4
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 17-1573V
(Not to be Published)
* * * * * * * * * * * * * * * * * * * * * * * * *
GARY L. LARSON, *
*
Petitioner, * Filed: March 28, 2019
*
v. *
* Entitlement; Decision by Proffer; Damages;
SECRETARY OF HEALTH AND * Influenza (“Flu”) Vaccine; Guillain-Barré
HUMAN SERVICES, * syndrome (“GBS”).
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
Glen Howard Sturtevant, Jr., Rawls Law Group, Richmond, VA, for Petitioner.
Jennifer Leigh Reynaud, U.S. Dep’t of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On October 20, 2017, Petitioner Gary Larson filed a petition seeking compensation under
the National Vaccine Injury Compensation Program.2 Petitioner alleges that he developed
Guillain-Barré syndrome (“GBS”) as a result of receiving an influenza (“flu”) vaccine on October
23, 2014.3 Petition, ECF No. 1.
1 Because this decision contains a reasoned explanation for my actions in this case, I will post it on the
United States Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44
U.S.C. § 3501 (2012). This means the ruling will be available to anyone with access to the internet.
As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion
of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine
Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that
statutory prefix).
3 This case was assigned to now-retired Special Master Hastings (ECF No. 6), reassigned to Special Master
Corcoran on September 20, 2017 (ECF No. 27), and then reassigned to my docket on December 7, 2017
(ECF No. 21).

Case 1:17-vv-01573-UNJ Document 34 Filed 07/29/19 Page 2 of 4
On September 17, 2018, Respondent filed a Rule 4(c) Report (“Respondent’s Report”) in
which he conceded that Petitioner is entitled to compensation for his claim of GBS. Respondent’s
Report, ECF No. 17. Specifically, Respondent stated that the medical evidence demonstrates
Petitioner has “satisfied the criteria set forth in the Vaccine Injury Table (“Table”) and the
Qualifications and Aids to Interpretation (“QAI”).” Id. at 8. Accordingly, Respondent concluded
that Petitioner is entitled to an award of damages limited to Petitioner’s “GBS and its related
sequelae only.” Id.
In light of Respondent’s concession, I issued a Ruling on Entitlement on September 18,
2018. ECF No. 18. I subsequently ordered the parties to inform the Court on their progress towards
resolving damages. See Damages Order, ECF No. 19.
Respondent filed a proffer on March 27, 2019 (ECF No. 27), agreeing to issue the following
payments:
a. a lump sum payment of $60,000.
These amounts represent all elements of compensation for all damages that would be
available under § 300aa-15(a).
I adopt the parties’ proffer attached hereto, and award compensation in the amount and on
the terms set forth therein. I, therefore, award compensation in the amount of a lump sum
payment of $60,000.00, in the form of a check payable to Petitioner, Gary L. Larson. The
clerk of court is directed to enter judgment in accordance with this decision.4
IT IS SO ORDERED.
/s/ Katherine E. Oler
Katherine E. Oler
Special Master
4 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.
2

Case 1:17-vv-01573-UNJ Document 34 Filed 07/29/19 Page 3 of 4
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
GARY L. LARSON,
Petitioner, No. 17-1573V
v. Chief Special Master Dorsey
ECF
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
PROFFER ON AWARD OF DAMAGES
On October 20, 2017, Gary L. Larson (“petitioner”) filed a petition for compensation
(“Petition”) under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -
34 (“Vaccine Act” or “Act”), as amended. Respondent conceded petitioner’s entitlement to
compensation in his Rule 4(c) Report filed on September 17, 2018. Based on Respondent’s Rule
4(c) Report the Chief Special Master found petitioner entitled to compensation.
I. Items of Compensation
Based upon the evidence of record, respondent proffers that petitioner should be awarded
$60,000.00, which represents all elements of compensation to which petitioner would be entitled
under 42 U.S.C. § 300aa-15(a). Petitioner agrees.
II. Form of the Award
Respondent recommends that the compensation provided to petitioner should be made
through a lump sum payment of $60,000.00, in the form of a check made payable to petitioner. 1
Petitioner agrees.
1 Should petitioner die prior to the entry of judgment, the parties reserve the right to move the
Court for appropriate relief. In particular, respondent would oppose any award for future
medical expenses, future lost earnings, and future pain and suffering.
1

Case 1:17-vv-01573-UNJ Document 34 Filed 07/29/19 Page 4 of 4
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respectfully submitted,
JOSEPH H. HUNT
Assistant Attorney General
C. SALVATORE D’ALESSIO
Acting Director
Torts Branch, Civil Division
CATHARINE E. REEVES
Deputy Director
Torts Branch, Civil Division
ALEXIS B. BABCOCK
Assistant Director
Torts Branch, Civil Division
s/Jennifer L. Reynaud
JENNIFER L. REYNAUD
Trial Attorney
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, D.C. 20044-0146
Tel: (202) 305-1586
Date: March 27, 2019
2